Genomics Could Blow Up the Clinical Trial

Genomic technology could accelerate patient trials of new cancer drugs that are targeted to a tumor’s individual molecular profile.MIT Technology Review: November 12, 2013

A novel kind of clinical trial is set to test several new lung cancer drugs based on the molecular profiles of each participating patient’s tumor.If successful, the trial could help bring cancer-genome-targeted medicines to patients more quickly than has been possible to date. Trials often only test one new drug at a time, and in cases when researchers do use genomic profiling to match a patient to a new treatment, they may struggle to find suitable candidates. Read More